[Question] thymosin — what am I missing here
thymosin — what am I missing here. I would rather ask a basic question now than get this wrong quietly for two months.
Bought small on anything without a testing history here. That rule has never once cost me anything.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
The three questions to ask before ordering anything from the long tail of a catalogue.
What exactly is it — catalogue number or sequence, not a common name, because several common names map to more than one molecule. How was identity established — mass against theoretical, ideally, rather than a bare purity figure. What are the storage conditions, stated specifically, with a state and a duration attached.
Then two commercial questions that save time: is this a stocked line or made to order, and what is the lead time in writing. All five are one email, and the shape of the reply tells you a great deal before any material moves.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.
Has anyone here tested that compound at all?
Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.
Purity methods differ by compound class.
This is the rule for anything unusual. Identity before anything else.
Push back: handling advice from one compound does not transfer to another just because both are peptides.
That result is an area percent from an unspecified method, which is not the same as the identity confirmation being discussed.
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
Same. Net peptide content is where the difference between the label and the vial actually shows up.
Correcting my own comment: the storage condition I quoted was for the lyophilised powder, not for solution.
Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.
Cosigning the lead-time point. Made-to-order and stocked are completely different propositions and both are legitimate.
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
- 1Purity methods differ by compound class. A gradient and wavelength developed…6 comments in this branch · started by u/naomi_antonsen